Loading...
Please wait, while we are loading the content...
Similar Documents
Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users
| Content Provider | Semantic Scholar |
|---|---|
| Author | Smith, Dawn K. Martin, Michael Lansky, Amy Mermin, Jonathan Choopanya, Kachit |
| Copyright Year | 2013 |
| Abstract | On June 12, 2013, the Thailand Ministry of Health and CDC published results from a randomized controlled trial of a daily oral dose of 300 mg of tenofovir disoproxil fumarate (TDF) that showed efficacy in reducing the acquisition of human immunodeficiency virus (HIV) infection among injecting drug users (IDUs) (1). Based on these findings, CDC recommends that preexposure prophylaxis (PrEP) be considered as one of several prevention options for persons at very high risk for HIV acquisition through the injection of illicit drugs. |
| Starting Page | 463 |
| Ending Page | 465 |
| Page Count | 3 |
| File Format | PDF HTM / HTML |
| PubMed reference number | 23760186 |
| Journal | Medline |
| Volume Number | 62 |
| Alternate Webpage(s) | https://stacks.cdc.gov/view/cdc/23107/cdc_23107_DS1.pdf |
| Journal | MMWR. Morbidity and mortality weekly report |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |